What is the best pharmacologic treatment for sickle cell disease pain crises? (avaa uuden ikkunan)

Baker M, Hafner JW.

Lähde‎: Ann Emerg Med 2012;59(6):515-6.

Arkistoitu‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (avaa uuden ikkunan)

Update on pain management in sickle cell disease. (avaa uuden ikkunan)

Ballas SK.

Lähde‎: Hemoglobin 2011;35(5-6):520-9.

Arkistoitu‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (avaa uuden ikkunan)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (avaa uuden ikkunan)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Lähde‎: Thromb Haemost 2007;98(2):392-6.

Arkistoitu‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (avaa uuden ikkunan)

Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. (avaa uuden ikkunan)

Tanabe P, Hafner JW, Martinovich Z, Artz N.

Lähde‎: Acad Emerg Med 2012;19(4):430-8.

Arkistoitu‎: PubMed 22506947

DOI‎: 10.1111/j.1553-2712.2012.01330.x

https://www.ncbi.nlm.nih.gov/pubmed/22506947 (avaa uuden ikkunan)

Management of sickle cell disease. (avaa uuden ikkunan)

de Montalembert M.

Lähde‎: BMJ 2008;337:a1397.

Arkistoitu‎: PubMed 18779222

https://www.ncbi.nlm.nih.gov/pubmed/18779222 (avaa uuden ikkunan)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (avaa uuden ikkunan)

Okomo U, Meremikwu MM.

Lähde‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Arkistoitu‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (avaa uuden ikkunan)

Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease. (avaa uuden ikkunan)

Ip H, Kesse-Adu R, Howard J, Hart N.

Lähde‎: Br J Haematol 2013;161(3):455-6.

Arkistoitu‎: PubMed 23419066

DOI‎: 10.1111/bjh.12254

https://www.ncbi.nlm.nih.gov/pubmed/23419066 (avaa uuden ikkunan)

Guidelines for the management of the acute painful crisis in sickle cell disease. (avaa uuden ikkunan)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Lähde‎: Br J Haematol 2003;120(5):744-52.

Arkistoitu‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (avaa uuden ikkunan)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (avaa uuden ikkunan)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Lähde‎: Diving Hyperb Med 2012;42(2):82-4.

Arkistoitu‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (avaa uuden ikkunan)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (avaa uuden ikkunan)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Lähde‎: Hemoglobin 2004;28(2):85-102.

Arkistoitu‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (avaa uuden ikkunan)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (avaa uuden ikkunan)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Lähde‎: N Engl J Med 1995;333(11):699-703.

Arkistoitu‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (avaa uuden ikkunan)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (avaa uuden ikkunan)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Lähde‎: J Investig Med 2008;56(8):1023-7.

Arkistoitu‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (avaa uuden ikkunan)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (avaa uuden ikkunan)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Lähde‎: N Engl J Med 2000;342(25):1855-65.

Arkistoitu‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (avaa uuden ikkunan)